Stockreport

Nemaura Announces CE Mark Approval of SugarBEAT®

Nemaura Medical Inc.  (NMRD) 
NASDAQ:AMEX Investor Relations: nemauramedical.com/investors
PDF Loughborough,England, May 29, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a [Read more]